What's Covered in this Webinar?

This webinar recording provides a regulatory perspective on what is expected from an independent and objective assessment of clinical data.
Discussion points include;

  • What the FDA and EMA are encouraging Sponsors to look at as part of their assessment of data quality.
  • Identifying the different types of data analysis required to de-risk studies
  • A review of case studies that exemplify a powerful approach to data management

Got a question? Give us a call on 0032 10 77 89 10, or send us an email to contact@cluepoints.com